-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2025.
- OnKure Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$14M, a 31.8% decline year-over-year.
- OnKure Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$51.1M, a 48% decline from 2023.
- OnKure Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$34.5M, a 27.1% increase from 2022.
- OnKure Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$47.4M, a 24.7% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)